The increasing difficulty of obtaining commercial support in the new regulatory environment, the explosive growth in MECCs, and other CME provider dilemmas were on the agenda at a session led by Wanda Johnson, CMP, senior director, meetings and education with The Endocrine Society, at the Professional Convention Management Association Annual Meeting in January. One impact of the new OIG guidance and PhRMA code on CME providers is that the systems pharma companies are developing for ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the Commercial Support Gets Even Tougher, you'll also gain access to exclusive premium content.

Already registered? here.